Literature DB >> 11347737

Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999.

R Nishimura1, R E LaPorte, J S Dorman, N Tajima, D Becker, T J Orchard.   

Abstract

OBJECTIVES: To investigate long-term mortality and its temporal trends as of 1 January 1999 among the 1,075 patients with type 1 diabetes (onset age <18 years, diagnosed between 1965 and 1979) who comprise the Allegheny County population-based registry. RESEARCH DESIGN AND METHODS: Overall, sex- and race-specific mortality rates per person-year of follow-up were determined. Standardized mortality ratios were also calculated. Survival analyses and Cox proportional hazard model were also used. Temporal trends were examined by dividing the cohort into three groups by year of diagnosis (1965-1969, 1970-1974, and 1975-1979).
RESULTS: Living status of 972 cases was ascertained as of January 1, 1999 (ascertainment rate 90.4%). The mean duration of diabetes was 25.2 +/- 5.8 (SD) years. Overall, 170 deaths were observed. The crude mortality rate was 627 per 100,000 person-years (95% CI 532-728) and standardized mortality ratio was 519 (440-602). Life-table analyses by the Kaplan-Meier method indicated cumulative survival rates of 98.0% at 10 years, 92.1% at 20 years, and 79.6% at 30 years duration of diabetes. There was a significant improvement in the survival rate between the cohort diagnosed during 1965-1969 and that diagnosed during 1975-1979 by the log-rank test (P = 0.03). Mortality was higher in African-Americans than in Caucasians, but there were no differences seen by sex. The improvement in recent years was seen in both ethnic groups and sexes.
CONCLUSIONS: An improvement in long-term survival was observed in the more recently diagnosed cohort. This improvement is consistent with the introduction of HbA1 testing, home blood glucose monitoring, and improved blood pressure therapy in the 1980s.

Entities:  

Mesh:

Year:  2001        PMID: 11347737     DOI: 10.2337/diacare.24.5.823

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  45 in total

1.  Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.

Authors:  M Nordwall; M Bojestig; H J Arnqvist; J Ludvigsson
Journal:  Diabetologia       Date:  2004-07-02       Impact factor: 10.122

2.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 3.  Type 1 diabetes in the young: the harvest of sorrow goes on.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2005-08       Impact factor: 10.122

4.  All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999.

Authors:  S S Soedamah-Muthu; J H Fuller; H E Mulnier; V S Raleigh; R A Lawrenson; H M Colhoun
Journal:  Diabetologia       Date:  2006-01-24       Impact factor: 10.122

5.  White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes.

Authors:  Karen A Nunley; Christopher M Ryan; Trevor J Orchard; Howard J Aizenstein; J Richard Jennings; John Ryan; Janice C Zgibor; Robert M Boudreau; Tina Costacou; John D Maynard; Rachel G Miller; Caterina Rosano
Journal:  Neurology       Date:  2015-04-22       Impact factor: 9.910

6.  Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.

Authors:  T Skrivarhaug; H-J Bangstad; L C Stene; L Sandvik; K F Hanssen; G Joner
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

7.  All-cause mortality in a population-based type 1 diabetes cohort in the U.S. Virgin Islands.

Authors:  Raynard E Washington; Trevor J Orchard; Vincent C Arena; Ronald E LaPorte; Aaron M Secrest; Eugene S Tull
Journal:  Diabetes Res Clin Pract       Date:  2013-12-27       Impact factor: 5.602

8.  Mortality risk prediction by an insurance company and long-term follow-up of 62,000 men.

Authors:  Eric J G Sijbrands; Erik Tornij; Sietske J Homsma
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

9.  Adiposity and mortality in type 1 diabetes.

Authors:  B Conway; R G Miller; T Costacou; L Fried; S Kelsey; R W Evans; T J Orchard
Journal:  Int J Obes (Lond)       Date:  2009-05-19       Impact factor: 5.095

Review 10.  The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens.

Authors:  Huey-Shi Lye; Chiu-Yin Kuan; Joo-Ann Ewe; Wai-Yee Fung; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2009-08-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.